Cell-Speci fi cDelivery of Diverse Cargos byBacteriophageMS 2 Virus-likeParticles

[1]  D. Peabody,et al.  Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles. , 2011, Journal of molecular biology.

[2]  Sonny C. Hsiao,et al.  Genome-free viral capsids as multivalent carriers for taxol delivery. , 2009, Angewandte Chemie.

[3]  David Vance,et al.  The design of polyvalent scaffolds for targeted delivery. , 2009, Advanced drug delivery reviews.

[4]  Sonny C. Hsiao,et al.  Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. , 2009, Journal of the American Chemical Society.

[5]  K. Lee,et al.  Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  Gary Siuzdak,et al.  Endothelial Targeting of Cowpea Mosaic Virus (CPMV) via Surface Vimentin , 2009, PLoS pathogens.

[7]  N. M. Moore,et al.  The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol‐based vehicles , 2008, The journal of gene medicine.

[8]  D. Peabody,et al.  Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2. , 2008, Journal of molecular biology.

[9]  Bradley C. Bundy,et al.  Escherichia coli‐based cell‐free synthesis of virus‐like particles , 2008, Biotechnology and bioengineering.

[10]  Mauro Ferrari,et al.  Nanogeometry: beyond drug delivery. , 2008, Nature nanotechnology.

[11]  Chin-Tarng Lin,et al.  Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery , 2008, Molecular Cancer Therapeutics.

[12]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[13]  M. Francis,et al.  Oxidative coupling of peptides to a virus capsid containing unnatural amino acids. , 2008, Chemical communications.

[14]  D. Peabody,et al.  Stability and assembly in vitro of bacteriophage PP7 virus-like particles , 2007, Journal of nanobiotechnology.

[15]  Marianne Manchester,et al.  Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. , 2007, Chemistry & biology.

[16]  M. Botta,et al.  Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies. , 2007, Nano letters.

[17]  Jacob M Hooker,et al.  Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system. , 2007, Bioconjugate chemistry.

[18]  P. Singh,et al.  Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging. , 2006, Advanced drug delivery reviews.

[19]  W. Fong,et al.  (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells. , 2006, Bioorganic & medicinal chemistry.

[20]  M. Izquierdo,et al.  Cyclin E1 knockdown induces apoptosis in cancer cells , 2006, Neurological research.

[21]  J. Yuan,et al.  Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo , 2006, Oncogene.

[22]  Andries Zijlstra,et al.  Viral nanoparticles as tools for intravital vascular imaging , 2006, Nature Medicine.

[23]  Marianne Manchester,et al.  Canine parvovirus-like particles, a novel nanomaterial for tumor targeting , 2006, Journal of nanobiotechnology.

[24]  Shiroh Futaki,et al.  High Density of Octaarginine Stimulates Macropinocytosis Leading to Efficient Intracellular Trafficking for Gene Expression* , 2006, Journal of Biological Chemistry.

[25]  R. Weissleder,et al.  Cell-specific targeting of nanoparticles by multivalent attachment of small molecules , 2005, Nature Biotechnology.

[26]  W. Brown,et al.  Delivery of antisense oligonucleotides to leukemia cells by RNA bacteriophage capsids. , 2005, Nanomedicine : nanotechnology, biology, and medicine.

[27]  S. Shih,et al.  Ricin Triggers Apoptotic Morphological Changes through Caspase-3 Cleavage of BAT3* , 2004, Journal of Biological Chemistry.

[28]  Jacob M Hooker,et al.  Interior surface modification of bacteriophage MS2. , 2004, Journal of the American Chemical Society.

[29]  Shiaw-Yih Lin,et al.  Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma. , 2003, Cancer research.

[30]  Yoshiaki Miyauchi,et al.  Cyclins and cyclin‐dependent kinases: Comparative study of hepatocellular carcinoma versus cirrhosis , 2003, Hepatology.

[31]  G. Yalcin,et al.  THE SPECTROPHOTOMETRIC DETERMINATION OF CISPLATIN IN URINE, USING o-PHENYLENEDIAMINE AS DERIVATIZING AGENT , 2001 .

[32]  D. Tzemach,et al.  Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  J. Kopeček,et al.  Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Henry Wilde,et al.  Medical Aspects of Chemical and Biological Warfare , 1998 .

[35]  O. Uhlenbeck,et al.  A coat for all sequences , 1998, Nature Structural Biology.

[36]  G. Klintmalm,et al.  Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in post-liver transplant patient plasma. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  P. Stockley,et al.  Cell-specific delivery of bacteriophage-encapsidated ricin A chain. , 1995, Bioconjugate chemistry.

[38]  D. Peabody,et al.  Encapsidation of heterologous RNAs by bacteriophage MS2 coat protein. , 1993, Nucleic acids research.

[39]  Seungpyo Hong,et al.  The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .

[40]  S. Wise.  Nanocarriers as an emerging platform for cancer therapy , 2007 .

[41]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.